At a glance
ClinicalIndex Comparison RecordN/ACompleted· 173 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Factors Influencing the Occurrence of Pancreatic Fistula After Minimally Invasive Pancreatic Enucleation and Predictive Models: a Prospective Cohort Study
In Brief
An observational study for Pancreatic Tumor, Benign and 2 related conditions. Completed, enrolled 173 participants across 1 site.
Detailed Summary
Patients suffering from postoperative pancreatic fistula (POPF) after minimally invasive enucleation (MIEN) show a characteristic pattern of longer duration and milder symptoms, which is different from pancreatic fistula after standard pancreatectomy. This study aimed to analyze the factors influencing clinically-relevant POPF (CR-POPF) after MIEN, investigate and develop a personalized predictive model for accurate prediction of CR-POPF.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPancreatic Tumor, Benign, Pancreatic Neuroendocrine Tumor, Solid Pseudopapillary Tumor of the Pancreas
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
Enrollment StartJul 2019
Primary CompletionNov 2022
Study CompletionJul 2024
First PostedAug 2024
TodayJul 2026
First PostedAug 16, 2024
Enrollment StartJul 1, 2019
Primary CompletionNov 30, 2022
Study CompletionJul 30, 2024
TodayJul 1, 2026
Enrollment to primary: 3.4 yearsPosted 1.9 years ago